No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy.
Schober SJ, Hallmen E, Reßle F, Gassmann H, Prexler C, Wawer A, von Luettichau I, Ladenstein R, Kazanowska B, Ljungman G, Niggli F, Lohi O, Hauer J, Gruhn B, Klingebiel T, Bader P, Burdach S, Lang P, Sparber-Sauer M, Koscielniak E, Thiel U.
Schober SJ, et al. Among authors: wawer a.
Front Oncol. 2022 May 10;12:878367. doi: 10.3389/fonc.2022.878367. eCollection 2022.
Front Oncol. 2022.
PMID: 35619911
Free PMC article.